Efficacy and safety of trelagliptin in Japanese patients with type 2 diabetes with severe renal impairment or end‐stage renal disease: Results from a randomized, phase 3 study

INTRODUCTION: To investigate the efficacy and safety of trelagliptin 25 mg in patients with type 2 diabetes mellitus with severe renal impairment or end‐stage renal disease. MATERIALS AND METHODS: This multicenter, randomized, phase 3 study comprised a 12‐week double‐blind phase followed by a 40‐wee...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaku, Kohei, Ishida, Kazuyuki, Shimizu, Kohei, Achira, Meguru, Umeda, Yuusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078116/
https://www.ncbi.nlm.nih.gov/pubmed/31389201
http://dx.doi.org/10.1111/jdi.13126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078116/
https://www.ncbi.nlm.nih.gov/pubmed/31389201
http://dx.doi.org/10.1111/jdi.13126

Ejemplares similares